Advisor Net Financial, Inc Zymeworks Inc. Transaction History

Advisor Net Financial, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 04, 2021	SELL	$39.12 - $54.99 $9,780 - $13,747	-250 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$29.21 - $46.58 $65,430 - $104,339	-2,240 Reduced 89.96%	250 $12,000
Q2 2020 Aug 26, 2020	SELL	$33.67 - $40.0 $70,033 - $83,200	-2,080 Reduced 45.51%	2,490 $90,000
Q1 2020 May 14, 2020	BUY	$24.28 - $49.8 $85,465 - $175,296	3,520 Added 335.24%	4,570 $162,000
Q4 2019 Feb 12, 2020	BUY	$24.84 - $45.46 $18,630 - $34,095	750 Added 250.0%	1,050 $48,000
Q3 2019 Oct 23, 2019	BUY	$22.78 - $29.08 $6,834 - $8,724	300 New	300 $7,000

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $917M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

Stay updated on Advisor Net Financial, Inc with notifications on news.